Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuelu Zhang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Therapy. Nucleic Acids|June 15, 2026
BRPtools: An AutoML-Powered web platform for multiclass disease prediction from bulk blood RNA-seq dataYichen Guo, Fengyuan Yang, Xuelu Zhang, et al.
Scientific Reports|April 2, 2026
Comparison of and risk factors for early and late pulmonary embolism in patients after major cancer surgeryYi Li, Lili Zhao, Qian Zhao, et al.
Frontiers in Immunology|August 11, 2025
Tumor-infiltrating lymphocytes in NSCLC: from immune surveillance to immunotherapyHaiyi Xue, Yilan Fan, Yi Li, et al.
Database : the Journal of Biological Databases and Curation|February 9, 2022
DDPD 1.0: a manually curated and standardized database of digital properties of approved drugs for drug-likeness evaluation and drug developmentQiang Li, Shiyong Ma, Xuelu Zhang, et al.
Nucleic Acids Research|October 22, 2022
OrganoidDB: a comprehensive organoid database for the multi-perspective exploration of bulk and single-cell transcriptomic profiles of organoidsQinfeng Ma, Haodong Tao, Qiang Li, et al.
Journal of Translational Medicine|October 29, 2025
Panmim: a resource of pan-cancer metastasis immune microenvironmentXuelu Zhang, Simeng Hu, Huanjing Hu, et al.
Nucleic Acids Research|October 16, 2022
PertOrg 1.0: a comprehensive resource of multilevel alterations induced in model organisms by in vivo genetic perturbationZhaoyu Zhai, Xuelu Zhang, Lu Zhou, et al.
Nucleic Acids Research|November 6, 2023
DiSignAtlas: an atlas of human and mouse disease signatures based on bulk and single-cell transcriptomicsZhaoyu Zhai, Zhewei Lin, Xuehang Meng, et al.
Signal Transduction and Targeted Therapy|April 30, 2023
Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cellsZiruoyu Wang, Yanan Li, Wensi Zhao, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Therapy. Nucleic Acids|June 15, 2026
BRPtools: An AutoML-Powered web platform for multiclass disease prediction from bulk blood RNA-seq dataYichen Guo, Fengyuan Yang, Xuelu Zhang, et al.
Scientific Reports|April 2, 2026
Comparison of and risk factors for early and late pulmonary embolism in patients after major cancer surgeryYi Li, Lili Zhao, Qian Zhao, et al.
Frontiers in Immunology|August 11, 2025
Tumor-infiltrating lymphocytes in NSCLC: from immune surveillance to immunotherapyHaiyi Xue, Yilan Fan, Yi Li, et al.
Database : the Journal of Biological Databases and Curation|February 9, 2022
DDPD 1.0: a manually curated and standardized database of digital properties of approved drugs for drug-likeness evaluation and drug developmentQiang Li, Shiyong Ma, Xuelu Zhang, et al.
Nucleic Acids Research|October 22, 2022
OrganoidDB: a comprehensive organoid database for the multi-perspective exploration of bulk and single-cell transcriptomic profiles of organoidsQinfeng Ma, Haodong Tao, Qiang Li, et al.
Journal of Translational Medicine|October 29, 2025
Panmim: a resource of pan-cancer metastasis immune microenvironmentXuelu Zhang, Simeng Hu, Huanjing Hu, et al.
Nucleic Acids Research|October 16, 2022
PertOrg 1.0: a comprehensive resource of multilevel alterations induced in model organisms by in vivo genetic perturbationZhaoyu Zhai, Xuelu Zhang, Lu Zhou, et al.
Nucleic Acids Research|November 6, 2023
DiSignAtlas: an atlas of human and mouse disease signatures based on bulk and single-cell transcriptomicsZhaoyu Zhai, Zhewei Lin, Xuehang Meng, et al.
Signal Transduction and Targeted Therapy|April 30, 2023
Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cellsZiruoyu Wang, Yanan Li, Wensi Zhao, et al.
Pageof 1